Showing results (161-170 of 202) with videos related to

Sort By:
Pageof 21
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 1982
Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjectsA D Mosnaim, F Karoum, A Zeller, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 1, 1994
Enhancement of natural killer cell activity in septic shock patients by a mixture of the calcium ionophore A23187 and the phorbol ester TPA: in vitro studiesJ Puente, T Carvajal, S Parra, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 1, 2013
The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping)P Amarenco, J Bogousslavsky, L R Caplan, et al.
Lancet (London, England)|August 25, 1984
Screening for hepatitis B virus markers is not justified in West African transfusion centresR W Ryder, H C Whittle, T Wojiecowsky, et al.
The New Zealand Dental Journal|January 9, 2014
Changes in Bachelor of Oral Health students' perceptions of their dental education environmentPage L A Foster, I Kang, V R Anderson, et al.
Vaccine|September 12, 2009
Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virusTania Cukalac, Jessica M Moffat, Vanessa Venturi, et al.
Genes and Immunity|September 7, 2002
Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndromeP J Tighe, S E Stevens, S Dempsey, et al.
Occupational and Environmental Medicine|October 16, 2007
A normative study of levels of uranium in the urine of British Forces personnelB G Miller, A P Colvin, P A Hutchison, et al.
Immunopharmacology|March 1, 1993
In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challengeA D Mosnaim, M E Wolf, P Maturana, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1995
Studies of natural killer cell activity in a drug-free, healthy population. Response to a challenge with taxol, estramustine and lipopolysaccharideJ Puente, M Diaz, M A Salas, et al.
Pageof 21